SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-012608
Filing Date
2017-11-27
Accepted
2017-11-27 16:40:16
Documents
2
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111617danenberg_wize.html 3  
1 OWNERSHIP DOCUMENT f3111617danenberg_wize.xml 3 3144
2 POWER OF ATTORNEY f3111617danenbergex24_wize.htm EX-24 7680
  Complete submission text file 0001213900-17-012608.txt   12317
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 BOROCHOV ST HOD HASHARON L3 4520404
Business Address
Danenberg Noam (Reporting) CIK: 0001720898 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52545 | Film No.: 171223305